These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24554520)
21. Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma. Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Xu J; Guo J BMC Cancer; 2017 Feb; 17(1):117. PubMed ID: 28178948 [TBL] [Abstract][Full Text] [Related]
22. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma. Li J; Sheng C; Li W; Zheng JH Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731 [TBL] [Abstract][Full Text] [Related]
23. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma. Qi C; Ma H; Zhang HT; Gao JD; Xu Y Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808 [TBL] [Abstract][Full Text] [Related]
24. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma. Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma. Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593 [TBL] [Abstract][Full Text] [Related]
26. Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC). Abbas M; Steffens S; Bellut M; Eggers H; Großhennig A; Becker JU; Wegener G; Schrader AJ; Grünwald V; Ivanyi P Med Oncol; 2016 Jul; 33(7):80. PubMed ID: 27317388 [TBL] [Abstract][Full Text] [Related]
27. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma. Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274 [TBL] [Abstract][Full Text] [Related]
28. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma. Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889 [TBL] [Abstract][Full Text] [Related]
30. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava. Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790 [TBL] [Abstract][Full Text] [Related]
31. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma. Ou C; Liu L; Wang J; Dai S; Qu Y; Xiong Y; Xi W; Xu J; Guo J Urol Oncol; 2017 Oct; 35(10):607.e1-607.e8. PubMed ID: 28619634 [TBL] [Abstract][Full Text] [Related]
33. Tspan8 Is Highly Expressed in Clear Cell Renal Cell Carcinoma and Indicates Poor Prognosis. Tang Y; Xie J; Chen Y; Zhang T; Zhuo H; Chen J; Yang P; Cui Q; Zhao L; Li L Ann Clin Lab Sci; 2020 Sep; 50(5):638-644. PubMed ID: 33067209 [TBL] [Abstract][Full Text] [Related]
34. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759 [TBL] [Abstract][Full Text] [Related]
35. A four-gene signature predicts survival in clear-cell renal-cell carcinoma. Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma. Li W; Liu M; Feng Y; Xu YF; Che JP; Wang GC; Zheng JH; Gao HJ Int J Clin Exp Pathol; 2013; 6(6):1086-94. PubMed ID: 23696926 [TBL] [Abstract][Full Text] [Related]
37. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma. Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752 [TBL] [Abstract][Full Text] [Related]
39. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival. Du P; Ye L; Yang Y; Jiang WG Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253 [TBL] [Abstract][Full Text] [Related]
40. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]